AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35509876 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure (3 days a week for 8 weeks)
Number of subjects: 99
Study 35509876 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercises (3 times a week for 8 weeks)
Number of subjects: 99
Study 35509876 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care in the oncology clinic)
Number of subjects: 99
Study 34835954 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Lactobacillus plantarum PS128
Number of subjects: 0
Study 34835954 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 36121246 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery denervation (PADN) plus a phosphodiesterase‐5 inhibitor
Number of subjects: 128
Study 36121246 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery denervation (PADN)
Number of subjects: 128
Study 36121246 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure plus a phosphodiesterase‐5 inhibitor
Number of subjects: 128
Study 33743111 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of four serum miRNAs (miR-4257, miR-6785-5p, miR-187-5p, and miR-5739)
Number of subjects: 1417
Study 33743111 — intervention group
Group type: COMPARATOR
Intervention: Non-cancer controls
Number of subjects: 1417
Study 35010502 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycyrrhiza uralensis extract gargle
Number of subjects: 60
Study 35010502 — intervention group
Group type: COMPARATOR
Intervention: Saline gargle
Number of subjects: 60
Study 34121477 — intervention group
Group type: EXPERIMENTAL
Intervention: Single medial incision
Number of subjects: 8
Study 34121477 — intervention group
Group type: COMPARATOR
Intervention: 2‐incision technique
Number of subjects: 8
Study 33276345 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behavior fragmentation (SBF)
Number of subjects: 34
Study 33276345 — intervention group
Group type: EXPERIMENTAL
Intervention: Light intensity physical activity (LIPA)
Number of subjects: 34
Study 33276345 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 34
Study 36314126 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 5741
Study 36314126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5741
Study 32805278 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related image included on dietary supplement packaging
Number of subjects: 1016
Study 35311937 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g in 100-mL intravenous bolus loading dose, followed by 1 g in 250-mL infusion within 8 hours of ICH onset)
Number of subjects: 219
Study 35311937 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline within 8 hours of ICH onset)
Number of subjects: 219
Study 35311937 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 219
Study 35311937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 32799365 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic polyethylene glycol (PEG) collagen membrane
Number of subjects: 30
Study 32799365 — intervention group
Group type: COMPARATOR
Intervention: Porcine-derived collagen membrane (CM)
Number of subjects: 30
Study 36029489 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (0.25-0.5 mg/day) for eight weeks
Number of subjects: 104
Study 36029489 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 104
Study 33249906 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E-infused highly crosslinked polyethylene (VEPE)
Number of subjects: 68
Study 33249906 — intervention group
Group type: COMPARATOR
Intervention: Moderately crosslinked polyethylene (ModXLPE)
Number of subjects: 68
Study 34724213 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% PVP-I nasal spray
Number of subjects: 0
Study 34724213 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0% PVP-I nasal spray
Number of subjects: 0
Study 34724213 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 0
Study 34724213 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (including placebo)
Number of subjects: 0
Study 34654501 — intervention group
Group type: EXPERIMENTAL
Intervention: CPP‐ACP
Number of subjects: 30
Study 34654501 — intervention group
Group type: EXPERIMENTAL
Intervention: NHA
Number of subjects: 30
Study 34654501 — intervention group
Group type: EXPERIMENTAL
Intervention: NovaMin®
Number of subjects: 30
Study 34654501 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 34654501 — intervention group
Group type: COMPARATOR
Intervention: Demineralization
Number of subjects: 30
Study 35228081 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene
Number of subjects: 0
Study 34373575 — intervention group
Group type: EXPERIMENTAL
Intervention: Cd2+ exposure for 3 hours (Gi 3h)
Number of subjects: 0
Study 34373575 — intervention group
Group type: EXPERIMENTAL
Intervention: Cd2+ exposure for 3 days (Gi 3d)
Number of subjects: 0
Study 34373575 — intervention group
Group type: COMPARATOR
Intervention: Control group (0h)
Number of subjects: 0
Study 32646501 — intervention group
Group type: EXPERIMENTAL
Intervention: unripe Rubus coreanus (uRC) 600 mg daily for 12 weeks
Number of subjects: 77
Study 32646501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 34170489 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for anorexia nervosa
Number of subjects: 228
Study 33567462 — intervention group
Group type: EXPERIMENTAL
Intervention: Pledgeted reinforced sutures
Number of subjects: 55
Study 33567462 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable mesh
Number of subjects: 55
Study 33567462 — intervention group
Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 55
Study 33837377 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs targeting IFNAR2
Number of subjects: 7554
Study 33837377 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs targeting ACE2
Number of subjects: 7554
Study 32459423 — intervention group
Group type: EXPERIMENTAL
Intervention: Elagolix 300 mg twice daily with hormonal add-back therapy (estradiol 1 mg and norethindrone acetate 0.5 mg once daily)
Number of subjects: 433
Study 32459423 — intervention group
Group type: EXPERIMENTAL
Intervention: Elagolix plus add-back therapy
Number of subjects: 433
Study 35246396 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal low-level laser therapy (LLLT)
Number of subjects: 80
Study 35246396 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture treatment (AT)
Number of subjects: 80
Study 33152029 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-gas concentration (FG)
Number of subjects: 48
Study 33152029 — intervention group
Group type: COMPARATOR
Intervention: Bispectral index-guided (BG)
Number of subjects: 48
Study 33152029 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study 34874182 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib plus endocrine therapy
Number of subjects: 5761
Study 34874182 — intervention group
Group type: COMPARATOR
Intervention: Endocrine therapy alone
Number of subjects: 5761
Study 32635503 — intervention group
Group type: EXPERIMENTAL
Intervention: Cod protein hydrolysate (CPH), 4 g daily for 8 weeks
Number of subjects: 30
Study 32635503 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 8 weeks
Number of subjects: 30
Study 32635503 — intervention group
Group type: EXPERIMENTAL
Intervention: Cod protein hydrolysate (CPH)
Number of subjects: 30
Study 32635503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 36347150 — intervention group
Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 90
Study 36347150 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 90
Study 34037151 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional bed bath
Number of subjects: 50
Study 34037151 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry bed bath
Number of subjects: 50
Study 32102615 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation (TAVI)
Number of subjects: 13
Study 34243225 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (1-hour session, 5 days a week for 1 month)
Number of subjects: 82
Study 34243225 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 82
Study 32554744 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical pessary
Number of subjects: 340
Study 32554744 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cerclage
Number of subjects: 340
Study 32554744 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cerclage plus vaginal progesterone
Number of subjects: 340
Study 32554744 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical pessary plus vaginal progesterone
Number of subjects: 340
Study 36189925 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid 0.2%/ Arnica extract 0.1% (Study Group)
Number of subjects: 52
Study 36189925 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic Acid 0.2% (Control Group)
Number of subjects: 52
Study 33438505 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced surgeon
Number of subjects: 12
Study 33438505 — intervention group
Group type: COMPARATOR
Intervention: Novice surgeon
Number of subjects: 12
Study 33438505 — intervention group
Group type: EXPERIMENTAL
Intervention: Both surgeons
Number of subjects: 12
Study 34191011 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban plus aspirin
Number of subjects: 0
Study 34191011 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 0
Study 34110842 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Feedback Program (PFP) providing feedback on genetically influenced risk factors for substance use and personalized recommendations/resources.
Number of subjects: 12000
Study 34110842 — intervention group
Group type: EXPERIMENTAL
Intervention: Online self-guided PFP developed in collaboration with professionals from student affairs and feedback from students.
Number of subjects: 12000
Study 33108633 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral siponimod 2 mg (initial dose titration over 6 days)
Number of subjects: 0
Study 33108633 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33769013 — intervention group
Group type: EXPERIMENTAL
Intervention: VirtualBasket technology
Number of subjects: 160
Study 33769013 — intervention group
Group type: COMPARATOR
Intervention: Regular mode (Control)
Number of subjects: 160
Study 35946019 — intervention group
Group type: COMPARATOR
Intervention: ACTH alone
Number of subjects: 100
Study 35946019 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH with Levetiracetam (LEV)
Number of subjects: 100
Study 32557338 — intervention group
Group type: EXPERIMENTAL
Intervention: Stronger postoperative analgesia (75/650 mg tramadol with paracetamol every 8 hours)
Number of subjects: 117
Study 34031117 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly haemodialysis with adjuvant pharmacological therapy for 6 weeks followed by thrice-weekly haemodialysis (incremental HD group)
Number of subjects: 50
Study 34031117 — intervention group
Group type: COMPARATOR
Intervention: Thrice-weekly haemodialysis (standard HD group)
Number of subjects: 50
Study 32281125 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorionic Villus Sampling (CVS)
Number of subjects: 22650
Study 33902372 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 1000 mg IV infusion
Number of subjects: 96
Study 33902372 — intervention group
Group type: COMPARATOR
Intervention: Pethidine 50 mg IV infusion
Number of subjects: 96
Study 33407589 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficient physical activity
Number of subjects: 4388
Study 33407589 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged screen time
Number of subjects: 4388
Study 33407589 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficient sleeping time
Number of subjects: 4388
Study 33407589 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of sugar‐sweetened beverage
Number of subjects: 4388
Study 33407589 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast food intake
Number of subjects: 4388
Study 33407589 — intervention group
Group type: EXPERIMENTAL
Intervention: Each additional lifestyle-related risk factor
Number of subjects: 4388
Study 32718934 — intervention group
Group type: EXPERIMENTAL
Intervention: DSNS breakfast/afternoon snack (Bkfst/AS)
Number of subjects: 81
Study 32718934 — intervention group
Group type: EXPERIMENTAL
Intervention: DSNS breakfast/prebed snack (Bkfst/PBS)
Number of subjects: 81
Study 32718934 — intervention group
Group type: COMPARATOR
Intervention: SSD group (control)
Number of subjects: 81
Study 35405771 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray titanium abutments
Number of subjects: 25
Study 35405771 — intervention group
Group type: EXPERIMENTAL
Intervention: Pink anodized titanium abutments
Number of subjects: 25
Study 35405771 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconia abutments
Number of subjects: 25
Study 35405771 — intervention group
Group type: EXPERIMENTAL
Intervention: Pink anodized and zirconia hybrid abutments
Number of subjects: 25
Study 35405771 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid zirconia abutments
Number of subjects: 25
Study 33407839 — intervention group
Group type: EXPERIMENTAL
Intervention: QPLEX™ Alz plus assay kit
Number of subjects: 300
Study 33570656 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-assisted dietary and exercise intervention
Number of subjects: 215
Study 33570656 — intervention group
Group type: COMPARATOR
Intervention: Control group (general advice session about pregnancy nutrition and weight management)
Number of subjects: 215
Study 36383222 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC-DMN
Number of subjects: 20
Study 36383222 — intervention group
Group type: COMPARATOR
Intervention: Drug-free DMN
Number of subjects: 20
Study 34459570 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate coronary angiography
Number of subjects: 554
Study 34459570 — intervention group
Group type: COMPARATOR
Intervention: Delayed or selective angiography
Number of subjects: 554
Study 32960175 — intervention group
Group type: EXPERIMENTAL
Intervention: SUPR (web-based self-management support program)
Number of subjects: 343
Study 32960175 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 343
Study 34226203 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week behaviour change intervention (weekly sessions with a physiotherapist)
Number of subjects: 70
Study 34226203 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention (weekly phone calls to monitor health status)
Number of subjects: 70
Study 35438802 — intervention group
Group type: COMPARATOR
Intervention: AZA (Azacitidine)
Number of subjects: 322
Study 35438802 — intervention group
Group type: EXPERIMENTAL
Intervention: AZA + Lenalidomide (LEN)
Number of subjects: 322
Study 35438802 — intervention group
Group type: EXPERIMENTAL
Intervention: AZA + Valproic Acid (VPA)
Number of subjects: 322
Study 35438802 — intervention group
Group type: EXPERIMENTAL
Intervention: AZA + Idarubicin (IDA)
Number of subjects: 322
Study 32054421 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish-borne trematode infections in wild fishes
Number of subjects: 65
Study 32054421 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticto barb (Puntius ticto)
Number of subjects: 65
Study 32054421 — intervention group
Group type: EXPERIMENTAL
Intervention: Banded gourami (Colisa fasciata)
Number of subjects: 65
Study 32054421 — intervention group
Group type: EXPERIMENTAL
Intervention: Freshwater garfish (Xenentodon cancila)
Number of subjects: 65
Study 32054421 — intervention group
Group type: EXPERIMENTAL
Intervention: Flying barb (Esomus danricus)
Number of subjects: 65
Study 32054421 — intervention group
Group type: EXPERIMENTAL
Intervention: Reba carp (Cirrhinus reba)
Number of subjects: 65
Study 32054421 — intervention group
Group type: COMPARATOR
Intervention: Body vs Head infection rates
Number of subjects: 65
Study 36047474 — intervention group
Group type: EXPERIMENTAL
Intervention: Ponesimod 20 mg
Number of subjects: 0
Study 36047474 — intervention group
Group type: COMPARATOR
Intervention: Teriflunomide 14 mg
Number of subjects: 0
Study 33284089 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein‐polyphenol beverage (PPB)
Number of subjects: 18
Study 33284089 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 18
Study 35392835 — intervention group
Group type: EXPERIMENTAL
Intervention: US-guided transoral core needle biopsy
Number of subjects: 112
Study 35392835 — intervention group
Group type: COMPARATOR
Intervention: US-guided transcutaneous core needle biopsy
Number of subjects: 112
Study 34117042 — intervention group
Group type: EXPERIMENTAL
Intervention: Early structured physiotherapy programme (ESP)
Number of subjects: 44
Study 34117042 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation under anaesthesia (MUA)
Number of subjects: 44
Study 34117042 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic capsular release (ACR)
Number of subjects: 44
Study 34117042 — intervention group
Group type: COMPARATOR
Intervention: Hydrodilatation
Number of subjects: 44
Study 32615727 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus sakei (CJLS03) 5×10^9 colony-forming units, administered for 12 weeks
Number of subjects: 114
Study 32615727 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equivalent vehicle), administered for 12 weeks
Number of subjects: 114
Study 34024615 — intervention group
Group type: EXPERIMENTAL
Intervention: External stent
Number of subjects: 184
Study 34024615 — intervention group
Group type: COMPARATOR
Intervention: Nonstented saphenous vein graft
Number of subjects: 184
Study 32877317 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 60
Study 32877317 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 35880559 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer-free stents (PFS)
Number of subjects: 1664
Study 35880559 — intervention group
Group type: COMPARATOR
Intervention: Polymer-coated stents (PCS)
Number of subjects: 1664
Study 32506861 — intervention group
Group type: EXPERIMENTAL
Intervention: Huatan Jieyu granules
Number of subjects: 107
Study 32506861 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment with prednisone
Number of subjects: 107
Study 35249798 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intensive educative program (5 hours a week)
Number of subjects: 60
Study 35249798 — intervention group
Group type: COMPARATOR
Intervention: Usual practice of an educative program (1 hour a week)
Number of subjects: 60
Study 33493406 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrap crural fixation
Number of subjects: 46
Study 33493406 — intervention group
Group type: COMPARATOR
Intervention: No wrap fixation (Control Group B)
Number of subjects: 46
Study 33170877 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based decision aid for colorectal cancer screening
Number of subjects: 1723
Study 33170877 — intervention group
Group type: COMPARATOR
Intervention: Control group (second reminder only)
Number of subjects: 1723
Study 35532913 — intervention group
Group type: EXPERIMENTAL
Intervention: ACI-24 vaccine (300 μg or 1000 μg)
Number of subjects: 16
Study 35532913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 34665203 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate hypothermia (31 °C)
Number of subjects: 389
Study 34665203 — intervention group
Group type: COMPARATOR
Intervention: Mild hypothermia (34 °C)
Number of subjects: 389
Study 33119643 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Restriction (SR)
Number of subjects: 0
Study 33119643 — intervention group
Group type: COMPARATOR
Intervention: Well-Restedness (WR)
Number of subjects: 0
Study 35485939 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly digital interventions assessing treatment adherence
Number of subjects: 29
Study 35485939 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 29
Study 33819218 — intervention group
Group type: EXPERIMENTAL
Intervention: Purse-string closure (Group A)
Number of subjects: 72
Study 33819218 — intervention group
Group type: COMPARATOR
Intervention: Linear closure (Group B)
Number of subjects: 72
Study 35610696 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily
Number of subjects: 60
Study 35610696 — intervention group
Group type: COMPARATOR
Intervention: Linagliptin 5 mg daily
Number of subjects: 60
Study 35710448 — intervention group
Group type: EXPERIMENTAL
Intervention: Online vestibular rehabilitation tool (YrselTräning)
Number of subjects: 320
Study 35710448 — intervention group
Group type: COMPARATOR
Intervention: Standard care (written instructions leaflet)
Number of subjects: 320
Study 32501212 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement appliance (MAA) therapy
Number of subjects: 18
Study 33728462 — intervention group
Group type: COMPARATOR
Intervention: Diethylcarbamazine and Albendazole (DA)
Number of subjects: 3816
Study 33728462 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin, Diethylcarbamazine, and Albendazole (IDA)
Number of subjects: 3816
Study 33728462 — intervention group
Group type: COMPARATOR
Intervention: Control (DA) and Intervention (IDA)
Number of subjects: 3816
Study 32022459 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 108
Study 36399252 — intervention group
Group type: EXPERIMENTAL
Intervention: Rise intervention (one-on-one counseling sessions using Motivational Interviewing)
Number of subjects: 166
Study 36399252 — intervention group
Group type: EXPERIMENTAL
Intervention: Rise intervention
Number of subjects: 166
Study 36399252 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 166
Study 34222771 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-volume surgeons
Number of subjects: 0
Study 34222771 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume surgeons
Number of subjects: 0
Study 34222771 — intervention group
Group type: COMPARATOR
Intervention: Very-low-volume surgeons
Number of subjects: 0
Study 34222771 — intervention group
Group type: COMPARATOR
Intervention: High-volume centres
Number of subjects: 0
Study 35640658 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian AUC24-48
Number of subjects: 65